MetLife Investment Management’s Mineralys Therapeutics MLYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $325K | Buy |
24,014
+7,232
| +43% | +$97.8K | ﹤0.01% | 1906 |
|
|
2025
Q1 | $266K | Sell |
16,782
-342
| -2% | -$5.43K | ﹤0.01% | 2046 |
|
|
2024
Q4 | $211K | Hold |
17,124
| – | – | ﹤0.01% | 2281 |
|
|
2024
Q3 | $207K | Hold |
17,124
| – | – | ﹤0.01% | 2270 |
|
|
2024
Q2 | $200K | Buy |
17,124
+5,708
| +50% | +$66.8K | ﹤0.01% | 2245 |
|
|
2024
Q1 | $147K | Hold |
11,416
| – | – | ﹤0.01% | 2353 |
|
|
2023
Q4 | $98.2K | Buy |
11,416
+4,353
| +62% | +$37.4K | ﹤0.01% | 2614 |
|
|
2023
Q3 | $67.2K | Hold |
7,063
| – | – | ﹤0.01% | 2780 |
|
|
2023
Q2 | $120K | Hold |
7,063
| – | – | ﹤0.01% | 2573 |
|
|
2023
Q1 | $111K | Buy |
+7,063
| New | +$111K | ﹤0.01% | 2504 |
|